Board of Directors

Philippe Chambon, MD, Ph.D.
Chairman
Philippe Chambon is a Managing Director and founder of New Leaf Venture Partners, a spin-off from The Sprout Group.  He joined Sprout in May 1995 and became a General Partner in January 1997.  He invests broadly in healthcare technology companies.  He currently is on the board of Auxilium Pharmaceuticals (AUXL) and PharSight (PHST) as well as several private companies.

Previously, Philippe served as Manager in the Healthcare Practice of The Boston Consulting Group from May 1993 to April 1995. From September 1987 to April 1993, he was an executive with Sandoz Pharmaceutical, where he led strategic product development, portfolio management and pre-marketing activities in his capacity as Executive Director of New Product Management. Philippe did graduate research in molecular immunology at The Pasteur Institute and earned a MD, Ph.D. from the University of Paris. He also has an MBA from Columbia University in New York.

Jeffrey H. Burbank
Jeff has more than 20 years’ experience with companies providing products for End Stage Renal Disease patients. He has led NxStage since its inception, guiding it through all of its developmental phases to the successful initiation of commercial activity and its recent initial public offering. Prior to founding NxStage, he co-founded Vasca, Inc., a company providing innovative implantable access devices, where he was the President and CEO, as well as Chairman of the Board. He gained significant renal industry experience during his nine years at Gambro, Inc., in the Renal Division, with his last position as Director of Marketing and Advanced Technologies. He is an inventor with 34 U.S. patents for medical devices.

Jeff received his BS in Industrial Engineering from Lehigh University and currently serves as an Executive Board Member of the National Kidney Foundation, and as a Director of Vasca and NxStage.

Daniel A. Giannini, CPA
Daniel, an executive advisor at the Advanced Technology Development Center of the Georgia Institute of Technology, has served as a director of NxStage since October 2005 and is a member of the Nominating and Corporate Governance Committee. He retired in June 2005 after a more than 30-year career as a Certified Public Accountant with PricewaterhouseCoopers LLP, most recently as an audit partner. He led the Technology, Information, Communications, and Entertainment practice at the firm’s Atlanta office. Daniel received a BS in Business Administration from LaSalle University.

Craig Moore
Craig has held a number of executive positions in the healthcare industry, including Chairman of the Board and CEO at Everest Healthcare Services Corporation prior to its acquisition by Fresenius Medical Care, Executive Vice President at Everest Healthcare, Division President of American Micro-Surgery Specialties at Baxter Healthcare Corporation, and Director for Biologic Systems Corporation.

Reid S. Perper
Reid has served as a director of NxStage since September 2005. Since May 2004, Reid has been a Managing Director of Healthcare Investment Partners LLC. Previously, he was a Managing Director and Co-Head of Europe for CSFB Private Equity. Prior to joining CSFB, he was a Managing Director of DLJ Merchant Banking Partners, the private equity arm of Donaldson, Lufkin & Jenrette.  Reid joined Donaldson, Lufkin & Jenrette in 1988.

Peter Phildius
Peter has been the Chairman and Chief Executive Officer of Avitar since 1991. Previously held executive positions include President and Chief Operating Officer of Delmed, Inc., President and Chief Operating Officer of National Medical Care, Inc. (now Fresenius Medical Care), Vice President and President of the Parenteral Division, President of the Artificial Organs Division, and President of the Fenwal Division at Baxter Healthcare Corporation.

David S. Utterberg
Between 1981 and 2007, David served as the Chief Executive Officer, President and sole stockholder of Medisystems Corporation, which was acquired by NxStage, together with certain affiliated entities, on October 1, 2007. He presently serves as the President and Director of Lifestream Medical Corporation, a medical device company, as well as the President, Director and Chairman of DSU Medical Corporation ("DSU"). DSU holds and licenses over 90 U.S. and foreign patents and other intellectual property in medical technology focused on extracorporeal therapy devices. He was also a director of Vasca, Inc., a medical device company that developed and marketed a blood access device for dialysis patients.